Questa pagina è stata tradotta automaticamente e l'accuratezza della traduzione non è garantita. Si prega di fare riferimento al Versione inglese per un testo di partenza.

Outpatient Physiotherapy vs. mHealth Exercise and Self-Management for Knee Osteoarthritis (MOKneeTOR) (MOKneeTOR)

31 agosto 2026 aggiornato da: Pua Yong Hao, Singapore General Hospital

Cost and Outcomes of Hospital-based Physiotherapy Versus mHealth-based Self-directed Rehabilitation in Patients With Knee Osteoarthritis: A Randomized, Controlled, Non-inferiority Trial

Symptomatic osteoarthritis (OA) of the knee affects approximately one-fifth (~300K) of Singaporeans aged 50 years or older, with the disease prevalence increasing with age. Patients with advanced knee OA and severe disability often require a total knee replacement (TKR) surgery. With an ageing population and the high prevalence of obesity, the annual number of TKRs is projected to rise. Thus, innovative care models are urgently needed to improve patient outcomes while managing or reducing the economic burden of this common and costly public health problem.

Unmet Need: Conservative treatment through physiotherapy rehabilitation is a key intervention, but significant access limitations result in unnecessary TKRs. For patients with knee OA, consensus guidelines are unanimous in recommending education, exercise, and weight management (if required) as first-line interventions. Physiotherapy rehabilitation incorporates these three first-line interventions and is a widely advocated and evidence-based component of OA management. Despite this, international evidence suggests that these core interventions are often under-utilized, with only 20-40% of community-dwelling older adults with knee OA receiving them. Locally and worldwide, suboptimal care from rehabilitation non-attendance is prevalent and costly: available research suggests that at least a quarter of TKRs could have been avoided with optimal care. Thus, to reduce the economic burden of OA, there is a need to develop innovative and flexible rehabilitation strategies.

A mobile health (mHealth)-based program is a likely solution to address this unmet need, but local contextualization is needed. Against this background, an mHealth-based OA self-management program may be a feasible solution to deliver guideline-based interventions, with minimal involvement by healthcare professionals. Whilst several app- or web-based OA self-management programs are available, few have undergone rigorous randomized controlled trial (RCT) evaluation, and still fewer provide detailed instructions to enable self-directed exercise (in particular, muscle strengthening exercises) - despite the evidence that exercise is the cornerstone of knee OA management. Furthermore, the reach and adoption of these programs in Singapore is limited as they are designed for English-speaking patients from Western cultures. Hence, whilst there are potential benefits in harnessing technology-enabled programs, these data emphasize the need for local co-design and adaptation to suit the Singapore context and to facilitate adoption.

Thus, the investigators have, through an iterative user-centered design process, developed Managing Osteoarthritis of the Knee using Therapist Technology Optimized Rehabilitation (MOKneeTOR), a blended digital rehabilitation program integrating an initial face-to-face physiotherapy assessment and an mHealth-enabled exercise and self-management program designed to promote first-line interventions (education, exercise, and weight management where indicated) for patients with knee osteoarthritis.

Panoramica dello studio

Descrizione dettagliata

Study Hypotheses

Primary hypothesis: The MOKneeTOR program will be non-inferior to hospital-based physiotherapy rehabilitation at 3 and at 6 months in improving physical function (fast gait speed).

Secondary hypothesis: The MOKneeTOR program will be more cost-effective than hospital-based physiotherapy rehabilitation in reducing total OA-related costs.

Approach and Methods

This will be an assessor-blinded, parallel design, non-inferiority randomized controlled trial, with assessments done at baseline, 3 months, and 6 months after randomization. The protocol conforms to the CONSORT guidelines for eHealth interventions and non-inferiority RCTs.

Participants

Study participants will be recruited from a large pool of patients who are referred by orthopaedic surgeons for conservative physiotherapy management in Singapore General Hospital (SGH). Informed, written consent by each participant will be obtained. Study treatments, but not the study hypotheses, will be disclosed to participants; therefore, participants will be unaware of the hypothesized direction of effect.

Randomization To maintain allocation concealment, randomization will be undertaken only after completion of baseline outcome assessment. Participants will be randomized using minimal sufficient balance (MSB) randomization, a covariate-adaptive randomization method designed to ensure covariate balance on the key variables of age, sex, treating physiotherapists, and baseline knee pain intensity. The first 20 patients will be allocated in a 1:1 ratio to MOKneeTOR program or outpatient physiotherapy rehabilitation program using simple randomization, after which the computer-generated MSB algorithm will be activated. To support an exploration of potential mechanisms through which our MOKneeTOR mobile app improves management adherence, participants randomized to the MOKneeTOR program will undergo a second randomization (1:1) to receive either (i) MOKneeTOR with the standard MOKneeTOR app configuration or (ii) MOKneeTOR with enhanced personalization of the MOKneeTOR app (e.g., personalized UI such as tailored caricature, preferred colour scheme and customizable chatbot settings that allow patients to choose between concise or detailed replies). Notably, this 2:1:1 design will optimize our ability to assess the overall effects of the MOKneeTOR program relative to outpatient physiotherapy rehabilitation program while also allow an exploration of potential mechanistic effects of the MOKneeTOR app.

Participants randomized to MOKneeTOR program may optionally nominate one adult support person (SP) (e.g., family member/friend) to receive access to an SP version of the MOKneeTOR mobile app. The SP app is a subset of the patient app and is intended to (i) improve SP's knee OA knowledge and (ii) support SP's efforts in supporting the participant's self-management. The SP app displays the participant's progress summaries (exercise and physical activity frequency) and delivers informational and encouragement messages to the SP. Participation of an SP is optional and does not affect the participant's clinical care or trial participation.

Tipo di studio

Interventistico

Iscrizione (Stimato)

160

Fase

  • Non applicabile

Contatti e Sedi

Questa sezione fornisce i recapiti di coloro che conducono lo studio e informazioni su dove viene condotto lo studio.

Contatto studio

Luoghi di studio

      • Singapore, Singapore
        • Reclutamento
        • Singapore General Hospital
        • Contatto:

Criteri di partecipazione

I ricercatori cercano persone che corrispondano a una certa descrizione, chiamata criteri di ammissibilità. Alcuni esempi di questi criteri sono le condizioni generali di salute di una persona o trattamenti precedenti.

Criteri di ammissibilità

Età idonea allo studio

  • Adulto
  • Adulto più anziano

Accetta volontari sani

No

Descrizione

Inclusion Criteria:

  • All patients who meet the knee OA clinical criteria (aged ≥45 years, activity-related knee pain, and ≤30 min knee joint stiffness in the morning) will be included,
  • an owner of a smartphone,
  • an education level of at least 8 years,
  • a willingness to be randomized to either MOKneeTOR program or outpatient rehabilitation program,
  • an ability to complete baseline assessment.

Exclusion Criteria:

  • lower limb joint replacement surgery anticipated within the next 6 months,
  • rheumatoid arthritis and other systemic arthritis,
  • a previous history of stroke and other major neurological conditions,
  • significant back or other non-knee pain,
  • pregnant women

Piano di studio

Questa sezione fornisce i dettagli del piano di studio, compreso il modo in cui lo studio è progettato e ciò che lo studio sta misurando.

Come è strutturato lo studio?

Dettagli di progettazione

  • Scopo principale: Trattamento
  • Assegnazione: Randomizzato
  • Modello interventistico: Assegnazione parallela
  • Mascheramento: Separare

Armi e interventi

Gruppo di partecipanti / Arm
Intervento / Trattamento
Comparatore attivo: Hospital-based outpatient rehabilitation program
Participants will attend, over a 12-week period, a minimum of 3 outpatient physiotherapy sessions, with up to 3 additional sessions if patients are deemed to require them.
Participants will attend, over a 12-week period, a minimum of 3 outpatient physiotherapy sessions, with up to 3 additional sessions if patients are deemed to require them. During the sessions, participants will receive patient education, exercises, manual therapy, and other modalities. Participants will also be instructed on a home exercise program in which they will exercise at least 3 times weekly. During each session which will last around 40 minutes, the project physiotherapist will (i) review the home exercise program, (ii) observe the participants performing the exercises and correct their form and techniques when necessary, and (iii) work with the participants to set goals and progress the exercise program.
Sperimentale: MOKneeTOR with standard app configuration
MOKneeTOR with standard app configuration will combine both self-reported outcomes and performance-based outcomes to provide objective exercise feedback and criterion-based personalized exercise progression recommendations.

Participants allocated to the MOKneeTOR program will receive 24 week access to the MOKneeTOR app. To onboard participants on the use of the MOKneeTOR app, the MOKneeTOR program is designed to include an in-person outpatient session, during which the physiotherapist will guide participants through the system. Importantly, based on assessment findings and data input by the physiotherapist, the MOKneeTOR app will utilize a care stratification approach by selecting educational materials tailored to the participant's needs.

Participants randomized to MOKneeTOR program may optionally nominate one adult support person (SP) (e.g., family member/friend) to receive access to an SP version of the MOKneeTOR mobile app. The SP app is a subset of the patient app and is intended to (i) improve SP's knee OA knowledge and (ii) support SP's efforts in supporting the participant's self-management.

Sperimentale: MOKneeTOR with standard app configuration and enhanced personalisation
MOKneeTOR with enhanced personalization will receive MOKneeTOR with standard app configuration and an app experience with an education chatbot that adapts tone, reading level, and format (text, infographics, short videos) to participants' preferences and engagement. Minor person-centred features (e.g., treating therapist caricature avatars and name-badged messages) will also be incorporated to strengthen therapeutic alliance without altering clinical guidance.
Participants randomized to receive MOKneeTOR with enhanced personalization of the MOKneeTOR app will receive an app experience with an education chatbot that adapts tone, reading level, and format (text, infographics, short videos) to participants' preferences and engagement. Minor person-centred features (e.g., treating therapist caricature avatars and name-badged messages) will also be incorporated to strengthen therapeutic alliance without altering clinical guidance.

Cosa sta misurando lo studio?

Misure di risultato primarie

Misura del risultato
Misura Descrizione
Lasso di tempo
Gait speed
Lasso di tempo: baseline, 3 months and 6 months post baseline visit
This provides a performance-based measure of physical function. Participants will walk at their usual pace (warm-up) and fast pace along a 4-metre walkway, with a 2.5-metre acceleration distance before and a 2.5-metre deceleration distance after the timed section. Gait timing will be captured concurrently using both a stopwatch and a time-of-flight sensor. Gait speed (m/s) will be calculated for both walking conditions; however, time-of-flight sensor-based fast-paced gait speed will be the primary outcome measure.
baseline, 3 months and 6 months post baseline visit

Misure di risultato secondarie

Misura del risultato
Misura Descrizione
Lasso di tempo
Knee strength
Lasso di tempo: baseline, 3 months and 6 months post baseline
Maximum quadriceps strength will be assessed on a seated knee extension machine using a standardized one repetition maximum (1RM) protocol.
baseline, 3 months and 6 months post baseline
Lower limb strength and mobility
Lasso di tempo: baseline, 3 months and 6 months post baseline
This will be measured by the 5-times sit-to-stand test. Participants will perform the tests at their usual (warm-up) and fast pace, and their timing will be concurrently captured using both a stopwatch and a smartphone.
baseline, 3 months and 6 months post baseline
Treatment satisfaction
Lasso di tempo: 3 months post baseline
Participants will rate their satisfaction with rehabilitation on a 11-point numeric rating scale, with 0 indicating "not at all satisfied " and 10 indicating "totally satisfied".
3 months post baseline
Treatment recommendation
Lasso di tempo: 3 months post baseline
Participants will rate how likely they are to recommend this treatment to a friend or family member with knee arthritis using an 11-point numeric rating scale (allowing for 0.5 increments). A score of 0 indicates "Not at all likely," and a score of 10 indicates "Extremely likely."
3 months post baseline
Global perceived effect (GROC)
Lasso di tempo: 3 months post baseline
GROC of overall change in pain and change in physical function since baseline will be measured using a 9-point ordinal scale, with 1 indicating "Much better" and 9 indicating "Much worse".
3 months post baseline
Exercise Compliance
Lasso di tempo: 3 months post baseline
Participants will respond to the question "I do my knee strengthening exercises as often as recommended/advised," using a 0-10 scale (0 = strongly disagree, 10 = strongly agree).
3 months post baseline
Exercise Compliance
Lasso di tempo: 3 months and 6 months post baseline
Participants will report their knee strenghtening exercise frequency (days per week).
3 months and 6 months post baseline
App usability
Lasso di tempo: 3 months post baseline
The usability of the MOKneeTOR app will be measured using the System Usability Scale (SUS), which is a validated 10 item questionnaire that assesses perceived usability. Qualitative feedback from participants will be collected to help identify intervention elements that are perceived to be useful. Additionally, user engagement and usage metrics will be automatically captured by the system backend throughout the study.
3 months post baseline
Short Form of the Western Ontario and McMaster Universities Osteoarthritis Index (ShortMAC F)
Lasso di tempo: baseline, 3 months and 6 months post baseline
The Short Form of the Western Ontario and McMaster Universities Osteoarthritis Index (ShortMAC-F) is an OA-specific questionnaire designed to measure physical function. Total scores range from 0 to 100, with higher scores representing greater function.
baseline, 3 months and 6 months post baseline
Knee Pain: Numeric Pain Rating Scale (NPRS)
Lasso di tempo: baseline, 3 months and 6 months post baseline
Knee pain intensity will be measured using the Numeric Pain Rating Scale (NPRS), inquiring about the average pain intensity level over the past 1 week. Scores range from 0 to 10, where higher scores indicate greater pain intensity.
baseline, 3 months and 6 months post baseline
Health-related quality of life - Euro Qol Group 5-Dimension (EQ-5D-5L)
Lasso di tempo: baseline, 3 months and 6 months post baseline
The EuroQol 5-Dimension 5-Level (EQ-5D-5L) is a health-related quality of life instrument with established psychometric properties in Singaporeans. Quality-adjusted-life-years (QALY), derived from the EQ-5D-5L utility index scores (which range from less than 0 to 1.0, where higher scores indicate a better health-related quality of life), will be the primary economic outcome used in the cost-utility analysis.
baseline, 3 months and 6 months post baseline
Cost outcomes: Healthcare utilization costs
Lasso di tempo: 3 months and 6 months post baseline
Between the baseline and the Month-6 assessment, the investigators will use the modified OA Cost and Consequences Questionnaire (OCC-Q) to measure the use of other health and home care services, including hospitalizations, co interventions, visits to healthcare providers (e.g., doctors and other healthcare professionals), and prescribed or over-the counter medications. The investigators will also collect information on participants' employment and income status and assess productivity losses, including restricted activity days (such as sick leave taken by participants and leave of absence taken by their caregivers).
3 months and 6 months post baseline

Altre misure di risultato

Misura del risultato
Misura Descrizione
Lasso di tempo
Adverse effects
Lasso di tempo: 3 months and 6 months post baseline
Adverse events (AE) and serious adverse events (SAE) will be recorded at all follow-ups by asking the participants about potential AEs using open-probe questioning to ensure that all AEs are recorded.
3 months and 6 months post baseline
Body weight and overall muscle mass/strength measurements [Mechanistic Outcome]
Lasso di tempo: baseline, 3 months and 6 months post baseline
This will be measured using a calibrated scale for body weight and bioelectrical impedance analysis (BIA) to assess body composition (e.g., fat mass, lean mass). As a proxy measure of overall muscle strength, handgrip strength of the dominant hand was measured using a Jamar Plus digital dynamometer. In the sitting position with the elbow flexed at 90degrees, each participant will perform three maximal trials with 30 s rest between trials, and the highest reading will be analyzed. These measures will help explore whether changes in body composition mediate improvements in physical function and pain.
baseline, 3 months and 6 months post baseline
Perceived TKR Necessity [Mechanistic Outcome]
Lasso di tempo: baseline, 3 months and 6 months post baseline
Participants will respond to the question "Based on your knee symptoms in the past week, how willing would you be to have knee surgery if you were medically fit to do so?" using a 0-10 scale (0 = not at all willing, 10 = definitely willing). They will also respond to the question "How necessary do you think knee replacement surgery is for your condition?" using a 0-10 scale (0 = not at all necessary, 10 = totally necessary).
baseline, 3 months and 6 months post baseline
Planned Walking Activities (IPEQ-W) [Mechanistic Outcome]
Lasso di tempo: baseline, 3 months and 6 months post baseline
Participants will report their planned walking activities using the walking subscale of the Incidental and Planned Exercise Questionnaire (IPEQ-W). They will indicate the frequency and duration of planned walking sessions over the past week. This measure captures structured walking exercise intended for health or fitness purposes, rather than incidental walking (e.g., walking for transport).
baseline, 3 months and 6 months post baseline
Knee range-of-motion
Lasso di tempo: baseline, 3 months and 6 months post baseline
A long-arm goniometer will be used to measure active-assisted knee flexion and extension range-of-motion with the participants in supine position.
baseline, 3 months and 6 months post baseline
Weight bearing symmetry [Mechanistic Outcome]
Lasso di tempo: baseline, 3 months and 6 months post baseline
This assesses the ability of the participants to weight bear on both limbs. With their feet on 2 portable force plate, participants will stand up from a standard chair, and weightbearing symmetry is calculated by expressing the peak force produced by the involved leg as a percentage of that produced by the uninvolved leg.
baseline, 3 months and 6 months post baseline
Pain self-efficacy [Mechanistic Outcome]
Lasso di tempo: baseline, 3 months and 6 months post baseline
This will be measured by the pain subscale of the Arthritis Self-Efficacy Scale (ASES), which measures a person's confidence in managing arthritis pain symptoms. Scores range from 1 to 10, where higher scores indicate greater self-efficacy.
baseline, 3 months and 6 months post baseline
OA knowledge [Mechanistic Outcome]
Lasso di tempo: baseline, 3 months and 6 months post baseline
This will be measured using the Knee Osteoarthritis Knowledge Scale (KOAKS). Total score ranges from 11 to 55, and higher scores indicate greater knowledge about osteoarthritis.
baseline, 3 months and 6 months post baseline
Fear of Movement [Mechanistic Outcome]
Lasso di tempo: baseline, 3 months and 6 months post baseline
This will be measured by the Brief Fear of Movement Scale for Osteoarthritis. Total scores range from 6 to 24, where higher scores indicate greater fear of movement and a worse outcome.
baseline, 3 months and 6 months post baseline
Psychological distress [Mechanistic Outcome]
Lasso di tempo: baseline, 3 months and 6 months post baseline
This will be measured by the Four-Dimensional Symptom Questionnaire (4DSQ). The distress subscale scores range from 0 to 32, where higher scores indicate higher psychological distress.
baseline, 3 months and 6 months post baseline
Family support [Mechanistic Outcome]
Lasso di tempo: baseline, 3 months and 6 months post baseline
This will be assessed using the Multidimensional Scale of Perceived Social Support (MSPSS), a validated 12-item questionnaire designed to measure perceived social support from family. Total scores range from 12 to 84, where higher scores indicate better perceived social support and a better outcome. In addition to the MSPSS, a study-specific questionnaire will be used.
baseline, 3 months and 6 months post baseline

Collaboratori e investigatori

Qui è dove troverai le persone e le organizzazioni coinvolte in questo studio.

Studiare le date dei record

Queste date tengono traccia dell'avanzamento della registrazione dello studio e dell'invio dei risultati di sintesi a ClinicalTrials.gov. I record degli studi e i risultati riportati vengono esaminati dalla National Library of Medicine (NLM) per assicurarsi che soddisfino specifici standard di controllo della qualità prima di essere pubblicati sul sito Web pubblico.

Studia le date principali

Inizio studio (Effettivo)

18 giugno 2026

Completamento primario (Stimato)

31 marzo 2027

Completamento dello studio (Stimato)

31 marzo 2027

Date di iscrizione allo studio

Primo inviato

11 agosto 2026

Primo inviato che soddisfa i criteri di controllo qualità

11 agosto 2026

Primo Inserito (Effettivo)

17 agosto 2026

Aggiornamenti dei record di studio

Ultimo aggiornamento pubblicato (Effettivo)

2 settembre 2026

Ultimo aggiornamento inviato che soddisfa i criteri QC

31 agosto 2026

Ultimo verificato

1 agosto 2026

Maggiori informazioni

Termini relativi a questo studio

Altri numeri di identificazione dello studio

  • Singapore General Hospital

Piano per i dati dei singoli partecipanti (IPD)

Hai intenzione di condividere i dati dei singoli partecipanti (IPD)?

SÌ

Descrizione del piano IPD

At the completion of the trial, de-identified individual participant data may be shared with qualified researchers upon request under a data-sharing agreement. Data released for secondary analyses will be further reviewed and redacted as necessary to protect participant privacy and confidentiality. All participants will be assigned a unique study ID and will not be identifiable by name. The data-sharing agreement will include provisions to safeguard participant privacy and data confidentiality.

Periodo di condivisione IPD

The data will be available starting 6 months after primary study publication.

Criteri di accesso alla condivisione IPD

Data will be made available upon reasonable written request to the study team. The PI, Dr. Yong-Hao Pua will review requests.

Tipo di informazioni di supporto alla condivisione IPD

  • STUDIO_PROTOCOLLO
  • LINFA
  • ICF

Informazioni su farmaci e dispositivi, documenti di studio

Studia un prodotto farmaceutico regolamentato dalla FDA degli Stati Uniti

No

Studia un dispositivo regolamentato dalla FDA degli Stati Uniti

No

Queste informazioni sono state recuperate direttamente dal sito web clinicaltrials.gov senza alcuna modifica. In caso di richieste di modifica, rimozione o aggiornamento dei dettagli dello studio, contattare register@clinicaltrials.gov. Non appena verrà implementata una modifica su clinicaltrials.gov, questa verrà aggiornata automaticamente anche sul nostro sito web .

Sottoscrivi